179 related articles for article (PubMed ID: 32878883)
1. Cardiac hypertrophy in a dish: a human stem cell based model.
Johansson M; Ulfenborg B; Andersson CX; Heydarkhan-Hagvall S; Jeppsson A; Sartipy P; Synnergren J
Biol Open; 2020 Sep; 9(9):. PubMed ID: 32878883
[TBL] [Abstract][Full Text] [Related]
2. RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model.
Aggarwal P; Turner A; Matter A; Kattman SJ; Stoddard A; Lorier R; Swanson BJ; Arnett DK; Broeckel U
PLoS One; 2014; 9(9):e108051. PubMed ID: 25255322
[TBL] [Abstract][Full Text] [Related]
3. Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus.
Tang L; Wang H; Dai B; Wang X; Zhou D; Shen J; Guo F; Wang J; Zhou J; Wang H; Wu Q; Yao H; Gong T; Su J; Meng ZX; Niu T; Zhang L; Liang P
J Mol Cell Cardiol; 2020 May; 142():53-64. PubMed ID: 32251671
[TBL] [Abstract][Full Text] [Related]
4. Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function.
Wnorowski A; Sharma A; Chen H; Wu H; Shao NY; Sayed N; Liu C; Countryman S; Stodieck LS; Rubins KH; Wu SM; Lee PHU; Wu JC
Stem Cell Reports; 2019 Dec; 13(6):960-969. PubMed ID: 31708475
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E
Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063
[TBL] [Abstract][Full Text] [Related]
6. Low-density plating is sufficient to induce cardiac hypertrophy and electrical remodeling in highly purified human iPS cell-derived cardiomyocytes.
Uesugi M; Ojima A; Taniguchi T; Miyamoto N; Sawada K
J Pharmacol Toxicol Methods; 2014; 69(2):177-88. PubMed ID: 24296355
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.
Wang YS; Zhou J; Hong K; Cheng XS; Li YG
Cell Physiol Biochem; 2015; 35(4):1546-56. PubMed ID: 25792377
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
Tanaka A; Yuasa S; Mearini G; Egashira T; Seki T; Kodaira M; Kusumoto D; Kuroda Y; Okata S; Suzuki T; Inohara T; Arimura T; Makino S; Kimura K; Kimura A; Furukawa T; Carrier L; Node K; Fukuda K
J Am Heart Assoc; 2014 Nov; 3(6):e001263. PubMed ID: 25389285
[TBL] [Abstract][Full Text] [Related]
9. Aberrant α-adrenergic hypertrophic response in cardiomyocytes from human induced pluripotent cells.
Földes G; Matsa E; Kriston-Vizi J; Leja T; Amisten S; Kolker L; Kodagoda T; Dolatshad NF; Mioulane M; Vauchez K; Arányi T; Ketteler R; Schneider MD; Denning C; Harding SE
Stem Cell Reports; 2014 Nov; 3(5):905-14. PubMed ID: 25418732
[TBL] [Abstract][Full Text] [Related]
10. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic Cardiomyopathy.
Knight WE; Cao Y; Lin YH; Chi C; Bai B; Sparagna GC; Zhao Y; Du Y; Londono P; Reisz JA; Brown BC; Taylor MRG; Ambardekar AV; Cleveland JC; McKinsey TA; Jeong MY; Walker LA; Woulfe KC; D'Alessandro A; Chatfield KC; Xu H; Bristow MR; Buttrick PM; Song K
Stem Cell Reports; 2021 Mar; 16(3):519-533. PubMed ID: 33636116
[TBL] [Abstract][Full Text] [Related]
11. Single-cell analysis reveals the purification and maturation effects of glucose starvation in hiPSC-CMs.
Ni X; Xu K; Zhao Y; Li J; Wang L; Yu F; Li G
Biochem Biophys Res Commun; 2021 Jan; 534():367-373. PubMed ID: 33279112
[TBL] [Abstract][Full Text] [Related]
12. Disease Modeling and Disease Gene Discovery in Cardiomyopathies: A Molecular Study of Induced Pluripotent Stem Cell Generated Cardiomyocytes.
Kumar S; Curran JE; Kumar K; DeLeon E; Leandro AC; Peralta J; Williams-Blangero S; Blangero J
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805011
[TBL] [Abstract][Full Text] [Related]
13. Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.
Ceholski DK; Turnbull IC; Kong CW; Koplev S; Mayourian J; Gorski PA; Stillitano F; Skodras AA; Nonnenmacher M; Cohen N; Björkegren JLM; Stroik DR; Cornea RL; Thomas DD; Li RA; Costa KD; Hajjar RJ
J Mol Cell Cardiol; 2018 Jun; 119():147-154. PubMed ID: 29752948
[TBL] [Abstract][Full Text] [Related]
14. Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes.
Lei W; Feng T; Fang X; Yu Y; Yang J; Zhao ZA; Liu J; Shen Z; Deng W; Hu S
Stem Cell Res Ther; 2018 Mar; 9(1):56. PubMed ID: 29523209
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK.
Shimojo N; Jesmin S; Zaedi S; Maeda S; Soma M; Aonuma K; Yamaguchi I; Miyauchi T
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H835-45. PubMed ID: 16501010
[TBL] [Abstract][Full Text] [Related]
16.
Higgins EM; Bos JM; Dotzler SM; John Kim CS; Ackerman MJ
Circ Genom Precis Med; 2019 Nov; 12(11):e002648. PubMed ID: 31638832
[TBL] [Abstract][Full Text] [Related]
17. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
[TBL] [Abstract][Full Text] [Related]
18. Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound.
Pohjolainen L; Kinnunen SM; Auno S; Kiriazis A; Pohjavaara S; Kari-Koskinen J; Zore M; Jumppanen M; Yli-Kauhaluoma J; Talman V; Ruskoaho H; Välimäki MJ
Stem Cell Res Ther; 2024 Jan; 15(1):5. PubMed ID: 38167208
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
[TBL] [Abstract][Full Text] [Related]
20. Human Induced Pluripotent Stem Cell-Derived Non-Cardiomyocytes Modulate Cardiac Electrophysiological Maturation Through Connexin 43-Mediated Cell-Cell Interactions.
Biendarra-Tiegs SM; Clemens DJ; Secreto FJ; Nelson TJ
Stem Cells Dev; 2020 Jan; 29(2):75-89. PubMed ID: 31744402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
